Overview

Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
To study the impact of 3 day exposure to atorvastatin 80mg on Annexin A5 targeting after ischemic exercise in the non-dominant forearm.
Phase:
Phase 4
Details
Lead Sponsor:
Radboud University
Collaborator:
Pfizer
Treatments:
Atorvastatin
Atorvastatin Calcium